AI-DRIVEN PRECISION MEDICINE
We are pioneering the science of accordant chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Significant safety improvement over existing drugs is a major driving force behind our approach; concomitant with that objective are novel mechanisms of action for healing respective indications.
Our innovative approach has already resulted in multiple drug candidates that are progressing in pre-clinical development. Each of these novel candidates is a result of improving a drug using our accordant chemistry platform technology, expanding the potential of a previously studied or approved drug.
UNPARALLELED SAFETY AND EFFICIENCY
Our Platform “accorClarity” drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Our approach provides a shortened regulatory pathway and reduced time and expense to commercialization. Furthermore, the endogenous moieties can provide added benefit through their anti-inflammatory and antimicrobial effects.